This systemic activation contributes to the anti-tumoral effects, but GT-00AxIL15 adds the benefit of targeting and retention in the tumor, thereby further enhancing local IL-15 concentrations in relation to the tolerable overall exposure. Here, IL15 is linked to neoplasm.